However, the mRNA expression of MyoD and IGF-I, reduced in the muscle atrophy control group (G2), was significantly elevated in both the 50 mg/kg and 100 mg/kg AJHW treatment groups (G4, G5), while myogenin mRNA expression, also reduced in the muscle atrophy control group (G2), substantially increased in all of the treatment groups (G4, G5, G6). Here, MYOG is linked to muscle atrophy.